DOCSLIB.ORG

Generate Metabolic Map Poster

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Generate Metabolic Map Poster An online version of this diagram is available at BioCyc.org. Biosynthetic pathways are positioned in the left of the cytoplasm, degradative pathways on the right, and reactions not assigned to any pathway are in the far right of the cytoplasm. Transporters and membrane proteins are shown on the membrane. Periplasmic (where appropriate) and extracellular reactions and proteins may also be shown. Pathways are colored according to their cellular function. Gcf_900635165Cyc: Escherichia coli servovar O2:K1:H4 str. NCTC11151 Cellular Overview Connections between pathways are omitted for legibility. 4-amino-4- deoxy-α-L- arabinopyranosyl ditrans,octacis -undecaprenyl putrescine putrescine glutathione thiosulfate a hexose 6- poly-β-1,6- phosphate L-tartrate N,N'- 3+ 3+ a dipeptide L-homoserine O-acetyl-L-serine O-acetyl-L-serine 1-(β-D 1-(β-D spermidine spermidine cys glutathione sulfate sulfate phosphate phosphate Fe Fe D-cellobiose an aromatic an aromatic thr diacetylchitobiose phosphate phosphate phosphate N-acetyl-D- thiamine thr (R)- cys cys spermidine spermidine succinate molybdate protoheme a hydroxamate a tripeptide amino acid amino acid shikimate ribofuranosyl) ribofuranosyl) ammonium sulfate sulfate sulfate phosphate (S)-lactate Fe 3+ glucosamine arbutin a dipeptide diphosphate pantothenate nicotinamide nicotinamide sulfate dCTP Fe 3+ salicin 4-amino-4-deoxy- predicted predicted predicted predicted predicted predicted predicted predicted predicted predicted L-arabinose- ABC ABC ABC ABC ABC ABC PEP-driven ABC ABC ATP-driven RS19820 RS16350 RS24005 RS10085 RS02420 phosphoundecaprenol RS06595 RS12535 RS22665 RS16660 transporter transporter RS12370 RS12375 transporter RS17955 transporter RS03340 RS04550 transporter RS07310 RS23450 RS23545 transporter RS20775 transporter of N,N'- RS00160 RS01195 RS03765 transporter RS22890 RS00585 RS08605 RS19380 RS17400 transporter transporter RS12190 RS15340 RS05700 RS00885 RS19605 RS12815 flippase of spermidine/ of spermidine/ of L-cysteine/ of glutathione of sulfate/ of sulfate diacetylchitobiose of phosphate of Fe3+ of Fe3+ putrescine putrescine glutathione thiosulfate poly-β-1,6- L-homoserine O-acetyl-L-serine O-acetyl-L-serine 1-(β-D 1-(β-D spermidine spermidine phosphate phosphate protoheme D-cellobiose 6'-phosphate an aromatic an aromatic thiamine thr (R)- molybdate dCTP a hydroxamate 3+ N-acetyl-D- thr shikimate cys cys ammonium succinate sulfate sulfate sulfate (S)-lactate Fe a tripeptide a dipeptide amino acid amino acid 4-amino-4- ribofuranosyl) ribofuranosyl) phosphate phosphate 3+ glucosamine arbutin-6-phosphate diphosphate pantothenate sulfate N,N'- a hexose 6- Fe deoxy-α-L- nicotinamide nicotinamide L-tartrate 3+ 3+ a dipeptide salicin 6-phosphate putrescine putrescine glutathione glutathione thiosulfate sulfate phosphate phosphate Fe Fe arabinopyranosyl diacetylchitobiose spermidine spermidine cys sulfate ditrans,octacis 6'-phosphate -undecaprenyl phosphate Cofactor, Carrier, and Vitamin Biosynthesis Nucleoside and Nucleotide Degradation Degradation/ Metabolic Regulator Biosynthesis Utilization/ an inactive a peptidoglycan dimer an O 6 - a nascent sn-glycero-3- UDP-N-acetyl- a holo-[EntF a [protein] N-acetyl-α- an N ω -(1- Assimilation - Other a reduced a [protein]- ditrans,octacis- peptidoglycan D- a lipid II a ribonucleoside an L-asparaginyl- an L-alanyl- superpathway of ubiquinol- superpathway of pyrimidine ribonucleoside methylguanine α formate Fermentation mixed acid fermentation SAM with pentapeptide L-cysteine undecaprenyldiphospho- peptidoglycan phospho-N- -D-muramoyl- L-seryl-carrier ser C-terminal glu D-muramoyl- Asn hydroxy-2- Pro biotin biosynthesis I superpathway of menaquinol-8 biosynthesis I [2Fe-2S] iron-sulfur superpathway of flavin biosynthesis I (bacteria and plants) prenylated superpathway of tetrahydrofolate biosynthesis superpathway of coenzyme A biosynthesis I (bacteria) 2-carboxy-1,4- adenosylcobinamide-GDP superpathway of pyridoxal 5'-phosphate biosynthesis and salvage thiamine salvage II NAD de novo biosynthesis NAD salvage ppGpp metabolism superpathway of purine deoxyribonucleosides degradation purine nucleotides degradation II (aerobic) superpathway of pyrimidine uracil degradation III acetoacetate flavodoxin alanyl-DAP crosslink diphosphate [tRNA ] [tRNA ] ATP 8 biosynthesis (prokaryotic) citrate lyase activation trehalose biosynthesis I glycine betaine deoxyribonucleosides degradation triphosphate stems (meso- in DNA N-acetyl-(N- (meso-DAP (arachidonoyl) L-alanyl-γ-D- protein] L-glutamate class 1b L-alanine(1-) oxopropyl) biotin xanthine xanthine cluster biosynthesis demethylmenaquinol-8 biosynthesis I FMNH naphthoquinol biosynthesis salvage from cobinamide I I (from aspartate) pathway III (to mannosylglycerate ribonucleosides degradation degradation RS17645 2 3-methyl-2- a 5,10- 4-amino-2-methyl-5- biosynthesis I reductase diaminopimelate acetylglucosaminyl) containing) ethanolamine glutamyl-meso-2,6- ribonucleoside- -[protein]- uracil uracil biosynthesis D-erythrose nicotinamide riboside) biosynthesis I phosphoenolpyruvate 2'-deoxycytidine uracil (to acetyl CoA) bifunctional murein serine-type formate IPP a malonyl-[acp] chorismate cob(II)inamide pyrimidinemethanol pppGpp D-glucopyranose (Gram-negative cytidine containing) bifunctional muramoyl-L-alanyl-γ- diaminopimeloyl- L-arginine L-cysteine desulfurase chorismate oxobutanoate methylenetetrahydrofolate chorismate 3'-dephospho-CoA 4-phosphate asp GDP-α-D- enterobactin D-Ala-D-Ala 30S ribosomal diphosphate N-acetylmuramoyl- aminoacyl-tRNA Cys- malonyl-ACP O- GTP GTP NADP + UDP-α-D-glucose 2'-deoxyguanosine AMP cytidine β DD-endopeptidase/ dehydrogenase- prenol DMAPP isochorismate cob(I)yrinic acid bifunctional 6-phosphate bacteria) cytidine pyrimidine utilization acetoacetate anaerobic DNA-binding D-isoglutaminyl-N-( - membrane-bound glycerophosphodiester D-alanyl-D-alanine biosynthesis carboxypeptidase: protein S6--L- reductase: L-alanine hydrolase: tRNA(Pro) bifunctional isopentenyl- isochorismate erythrose-4- L-aspartate mannose deaminase: acetoacetyl-CoA murein LD- N subunit methyltransferase isochorismate 3-methyl-2-oxobutanoate synthase a,c-diamide 2-(5''-triphosphoribosyl)- hydroxymethylpyrimidine GTP choline pyruvate kinase: pyk phosphoenolpyruvate deaminase: 2'-deoxyadenosine ribonucleoside- transcriptional D-asparaginyl)-L-lysyl- phosphodiesterase: glutamate ligase: nrdF nrdE amidase EL024_RS14245 /Cys- biotin-- uracil RS06995 uracil choline RS18560 choline synthase cysteine GTP phosphate oxidase: EL024_RS08895 protein A: rutA N-acetylmuramoyl- lytic murein carboxypeptidase: bifunctional EL024_RS02795 protein alpha: fdnG diphosphate BioC: bioC synthase GTP hydroxymethyltransferase: adenosyltransferase: guanosine-5'- alpha,alpha- pyruvate kinase I: carboxylase: bifunctional UDP- transferase: regulator/O6- D-alanyl-D-alanine [acetyl-CoA- a malonyl-[acp] MenF: menF desulfurase MenF: menF 3'-dephosphocoenzyme- kinase/ EL024_RS06615 pyrophosphokinase: guanosine-3',5'- 2-O-(α-D- EL024_RS08895 thymidine triphosphate L-alanine transglycosylase EL024_RS08425 serine-type isochorismatase/ [+ 3 isozymes] EL024_RS16155 ribonucleotide- AmiB: amiB aminoacyl-tRNA deglycase tRNA(Cys) Delta-isomerase: cyclohydrolase dehydrogenase: + sugar hydrolase/ uridine EL024_RS08500 EL024_RS08725 formate MenF: menF cyclohydrolase panB isochorismate [corrinoid cobO A synthase: phosphomethylpyrimidine 2-iminosuccinate NAD EL024_RS05340 bis(diphosphate) triphosphate,3'- trehalose- EL024_RS11965 EL024_RS23235 purine-nucleoside reductase- methylguanine-DNA deacylase carboxylase] methyl ester CsdA: csdA mannosyl)- 5 amidase MltC: mltC glycerophosphodiester D-Ala-D-Ala aryl carrier diphosphate [+ 3 isozymes] hydrolase: HchA: hchA EL024_RS04755 isochorismate II: ribA I FolE: folE EL024_RS04575 diphosphate phosphate thymidine 5'-nucleotidase: uridine FMN-N -oxide (Z)-3-ureidoacrylate acetoacetyl-CoA methyltransferase murein DD- dehydrogenase- ligase/biotin adenosyltranferase]- EL024_RS17290 kinase: thiD 3'-diphosphatase: betaine aldehyde 2'-deoxyuridine adenosine phosphorylase: activating protein: protein EntB: YbaK: ybaK + + beta-ketoacyl- [+ 2 isozymes] isochorismate 2,5-diamino-6- 7,8- 4-phospho- NAD(+) 3-phospho- EL024_RS17810 AmiB: amiB peptidoglycan [+ 2 isozymes] phosphodiesterase: carboxypeptidase: a N- a [protein] C- reductase: EL024_RS19180 protein H RS10640 H formate RS15870 formate asp 2-succinyl-5- α quinolinate EL024_RS00360 diphosphatase: synthase: phosphorylase: deoD phosphorylase: Ada: endopeptidase N subunit operon DMAPP (5-phospho-D- cob(II)inamide 2'-(5''-triphospho- -D- D-glycerate pyruvate oxaloacetate deaminase: acetyl-CoA C- EL024_RS21500 [+ 3 isozymes] glycosyltransferase EL024_RS01455 EL024_RS02795 EL024_RS17375 acetylglucosamine- terminal α-L- EL024_RS08440 N-acetyl-D- deglycase ACP synthase II: 2-succinyl-5- an S-sulfanyl-[L- prenyl phosphate dihydroneopterin 2-dehydropantoate enolpyruvyl- D-erythronate HMP-P synthase diphosphatase: deoA [+ 4 isozymes] GMP EL024_RS23885 EL024_RS08545 MepM: mepM D-ala alpha: fdnG repressor 2-succinyl-5- ribosylamino) ribosyl)-3'-dephospho-CoA EL024_RS24240 EL024_RS10875 mannosyl-3- EL024_RS12250 pyrimidine/purine ureidoacrylate FtsI: ftsI glutamate-α- EL024_RS08445 EL024_RS15010 cysteine desulfurase] 3'-triphosphate aspartate 1- 6-hydroxy-3- 4-phosphoerythronate EL024_RS23015 acetyltransferase: a mature a nascent [+ 3 isozymes] [+ 2 isozymes] -N-acetylmuramyl- a 2'- ala muramate YajL: yajL enolpyruvyl- 5-(2-hydroxyethyl) NadA: nadA Pro BirA: birA 2-dehydropantoate
Load more

Recommended publications
  • Intrinsically Disordered Proteins As Crucial Constituents of Cellular Aqueous Two Phase Systems and Coacervates ⇑ Vladimir N
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector FEBS Letters 589 (2015) 15–22 journal homepage: www.FEBSLetters.org Hypothesis Intrinsically disordered proteins as crucial constituents of cellular aqueous two phase systems and coacervates ⇑ Vladimir N. Uversky a,b,c,d, , Irina M. Kuznetsova d,e, Konstantin K. Turoverov d,e, Boris Zaslavsky f a Department of Molecular Medicine and USF Health Byrd Alzheimer’s Research Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA b Institute for Biological Instrumentation, Russian Academy of Sciences, Pushchino, Moscow Region, Russian Federation c Biology Department, Faculty of Science, King Abdulaziz University, P.O. Box 80203, Jeddah 21589, Saudi Arabia d Laboratory of Structural Dynamics, Stability and Folding of Proteins, Institute of Cytology, Russian Academy of Sciences, St. Petersburg, Russian Federation e St. Petersburg State Polytechnical University, St. Petersburg, Russian Federation f AnalizaDx Inc., 3615 Superior Ave., Suite 4407B, Cleveland, OH 44114, USA article info abstract Article history: Here, we hypothesize that intrinsically disordered proteins (IDPs) serve as important drivers of the Received 17 August 2014 intracellular liquid–liquid phase separations that generate various membrane-less organelles. This Revised 10 October 2014 hypothesis is supported by the overwhelming abundance of IDPs in these organelles. Assembly and Accepted 19 November 2014 disassembly of these organelles are controlled by changes in the concentrations of IDPs, their post- Available online 29 November 2014 translational modifications, binding of specific partners, and changes in the pH and/or temperature Edited by A. Valencia of the solution.
    [Show full text]
  • 要約) Doctoral Dissertation Antibiotics Shapes Population-Level Diversity In
    ) Doctoral Dissertation Antibiotics shapes population-level diversity in the human gut microbiome ( ) Nishijima Suguru Acknowledgments I would like to express my sincere gratitude to my supervisor, Prof. Masahira Hattori, whose expertise, knowledge and continuous encouragement throughout my research. My sincere thanks also go to Assoc. Prof. Kenshiro Oshima (The University of Tokyo), Dr. Wataru Suda and Dr. Seok-Won Kim for their motivation, immense support and encouragement throughout my work. I am also grateful to all my collaborators, Prof. Hidetoshi Morita (Okayama University) for his fecal sample collection, DNA isolation and sincere encouragement, Prof. Kenya Honda and Dr. Koji Atarashi (Keio University) for mice experiments, Assoc. Prof. Masahiro Umezaki (the University of Tokyo) for support for dietary data analysis, Dr. Todd D. Taylor (RIKEN) for support for writing manuscript and Dr. Yuu Hirose (Toyohashi University of technology) for DNA sequencing. I also would like to thank all past and present members of our laboratory, Erica Iioka, Misa Takagi, Emi Omori, Hiromi Kuroyamagi, Naoko Yamashita, Keiko Komiya, Rina Kurokawa, Chie Shindo, Yukiko Takayama and Yasue Hattori for their great technical support and kind assistance. i Antibiotics shapes population-level diversity in the human gut microbiome () Abstract The human gut microbiome has profound influences on the host’s physiology through its interference with various intestinal functions. The development of next-generation sequencing (NGS) technologies enabled us to comprehensively explore ecological and functional features of the gut microbiomes. Recent studies using the NGS-based metagenomic approaches have suggested high ecological diversity of the microbiome across countries. However, little is known about the structure and feature of the Japanese gut microbiome, and the factor that shapes the population-level diversity in the human gut microbiome.
    [Show full text]
  • Phospholipid:Diacylglycerol Acyltransferase: an Enzyme That Catalyzes the Acyl-Coa-Independent Formation of Triacylglycerol in Yeast and Plants
    Phospholipid:diacylglycerol acyltransferase: An enzyme that catalyzes the acyl-CoA-independent formation of triacylglycerol in yeast and plants Anders Dahlqvist*†‡, Ulf Ståhl†§, Marit Lenman*, Antoni Banas*, Michael Lee*, Line Sandager¶, Hans Ronne§, and Sten Stymne¶ *Scandinavian Biotechnology Research (ScanBi) AB, Herman Ehles Va¨g 2 S-26831 Svaloˆv, Sweden; ¶Department of Plant Breeding Research, Swedish University of Agricultural Sciences, Herman Ehles va¨g 2–4, S-268 31 Svalo¨v, Sweden; and §Department of Plant Biology, Uppsala Genetic Center, Swedish University of Agricultural Sciences, Box 7080, S-750 07 Uppsala, Sweden Edited by Christopher R. Somerville, Carnegie Institution of Washington, Stanford, CA, and approved March 31, 2000 (received for review February 15, 2000) Triacylglycerol (TAG) is known to be synthesized in a reaction that acid) and epoxidated fatty acid (vernolic acid) in TAG in castor uses acyl-CoA as acyl donor and diacylglycerol (DAG) as acceptor, bean (Ricinus communis) and the hawk’s-beard Crepis palaestina, and which is catalyzed by the enzyme acyl-CoA:diacylglycerol respectively. Furthermore, a similar enzyme is shown to be acyltransferase. We have found that some plants and yeast also present in the yeast Saccharomyces cerevisiae, and the gene have an acyl-CoA-independent mechanism for TAG synthesis, encoding this enzyme, YNR008w, is identified. which uses phospholipids as acyl donors and DAG as acceptor. This reaction is catalyzed by an enzyme that we call phospholipid:dia- Materials and Methods cylglycerol acyltransferase, or PDAT. PDAT was characterized in Yeast Strains and Plasmids. The wild-type yeast strains used were microsomal preparations from three different oil seeds: sunflower, either FY1679 (MAT␣ his3-⌬200 leu2-⌬1 trp1-⌬6 ura3-52) (9) or castor bean, and Crepis palaestina.
    [Show full text]
  • Progressive Increase in Mtdna 3243A>G Heteroplasmy Causes Abrupt
    Progressive increase in mtDNA 3243A>G PNAS PLUS heteroplasmy causes abrupt transcriptional reprogramming Martin Picarda, Jiangwen Zhangb, Saege Hancockc, Olga Derbenevaa, Ryan Golhard, Pawel Golike, Sean O’Hearnf, Shawn Levyg, Prasanth Potluria, Maria Lvovaa, Antonio Davilaa, Chun Shi Lina, Juan Carlos Perinh, Eric F. Rappaporth, Hakon Hakonarsonc, Ian A. Trouncei, Vincent Procaccioj, and Douglas C. Wallacea,1 aCenter for Mitochondrial and Epigenomic Medicine, Children’s Hospital of Philadelphia and the Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104; bSchool of Biological Sciences, The University of Hong Kong, Hong Kong, People’s Republic of China; cTrovagene, San Diego, CA 92130; dCenter for Applied Genomics, Division of Genetics, Department of Pediatrics, and hNucleic Acid/Protein Research Core Facility, Children’s Hospital of Philadelphia, Philadelphia, PA 19104; eInstitute of Genetics and Biotechnology, Warsaw University, 00-927, Warsaw, Poland; fMorton Mower Central Research Laboratory, Sinai Hospital of Baltimore, Baltimore, MD 21215; gGenomics Sevices Laboratory, HudsonAlpha Institute for Biotechnology, Huntsville, AL 35806; iCentre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, VIC 3002, Australia; and jDepartment of Biochemistry and Genetics, National Center for Neurodegenerative and Mitochondrial Diseases, Centre Hospitalier Universitaire d’Angers, 49933 Angers, France Contributed by Douglas C. Wallace, August 1, 2014 (sent for review May
    [Show full text]
  • Peroxisomal Fatty Acid Beta-Oxidation in Relation to the Accumulation Of
    Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. R J Wanders, … , A W Schram, J M Tager J Clin Invest. 1987;80(6):1778-1783. https://doi.org/10.1172/JCI113271. Research Article The peroxisomal oxidation of the long chain fatty acid palmitate (C16:0) and the very long chain fatty acids lignocerate (C24:0) and cerotate (C26:0) was studied in freshly prepared homogenates of cultured skin fibroblasts from control individuals and patients with peroxisomal disorders. The peroxisomal oxidation of the fatty acids is almost completely dependent on the addition of ATP, coenzyme A (CoA), Mg2+ and NAD+. However, the dependency of the oxidation of palmitate on the concentration of the cofactors differs markedly from that of the oxidation of lignocerate and cerotate. The peroxisomal oxidation of all three fatty acid substrates is markedly deficient in fibroblasts from patients with the Zellweger syndrome, the neonatal form of adrenoleukodystrophy and the infantile form of Refsum disease, in accordance with the deficiency of peroxisomes in these patients. In fibroblasts from patients with X-linked adrenoleukodystrophy the peroxisomal oxidation of lignocerate and cerotate is impaired, but not that of palmitate. Competition experiments indicate that in fibroblasts, as in rat liver, distinct enzyme systems are responsible for the oxidation of palmitate on the one hand and lignocerate and cerotate on the other hand. Fractionation studies indicate that in rat liver activation of cerotate and lignocerate to cerotoyl-CoA and lignoceroyl-CoA, respectively, occurs in two subcellular fractions, the endoplasmic reticulum and the peroxisomes but not in the mitochondria.
    [Show full text]
  • Dissertation Inês Silva ITQB.Pdf
    The Role of Small RNAs and Ribonucleases in the Control of Gene Expression in Salmonella Typhimurium Inês de Jesus de Almeida e Silva Insert here an image with rounded corners Dissertation presented to obtain the Ph.D degree in Biology Instituto de Tecnologia Química e Biológica | Universidade Nova de Lisboa Oeiras, December, 2012 The Role of Small RNAs and Ribonucleases in the Control of Gene Expression in Salmonella Typhimurium Inês de Jesus de Almeida e Silva Dissertation presented to obtain the Ph.D degree in Biology Instituto de Tecnologia Química e Biológica Universidade Nova de Lisboa Oeiras, December, 2012 Financial Support from Fundação para a Ciência e Tecnologia (FCT) – Ph.D: grant - SFRH / BD / 43211 / 2008. Work performed at: Control of Gene Expression Laboratory Instituto de Tecnologia Química e Biológica Av. da República (EAN) 2781-901 Oeiras – Portugal Tel: +351-21-4469548 Fax: +351-21-4469549 Supervisor : Professora Doutora Cecília Maria Pais de Faria de Andrade Arraiano – Investigadora Coordenadora, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa. (Head of the Laboratory of Control of Gene Expression, where the work of this Dissertation was performed) Co-supervisor : Doutora Sandra Cristina de Oliveira Viegas – Investigadora Pós-Doutorada, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa. (Post-doc Fellow in the Laboratory of Control of Gene Expression, where the work of this Dissertation was performed) President of the Jury : Doutora Claudina Amélia Marques Rodrigues Pousada – Professora Catedrática Convidada do Instituto de Tecnologia Química e Biológica da Universidade Nova de Lisboa, por delegação; iii Examiners: Professor Doutor Iñigo Lasa Uzcudun – Head of Microbial Biofilm Research Group, Instituto de Agrobiotecnología, Pamplona (Principal Examiner).
    [Show full text]
  • Yeast Genome Gazetteer P35-65
    gazetteer Metabolism 35 tRNA modification mitochondrial transport amino-acid metabolism other tRNA-transcription activities vesicular transport (Golgi network, etc.) nitrogen and sulphur metabolism mRNA synthesis peroxisomal transport nucleotide metabolism mRNA processing (splicing) vacuolar transport phosphate metabolism mRNA processing (5’-end, 3’-end processing extracellular transport carbohydrate metabolism and mRNA degradation) cellular import lipid, fatty-acid and sterol metabolism other mRNA-transcription activities other intracellular-transport activities biosynthesis of vitamins, cofactors and RNA transport prosthetic groups other transcription activities Cellular organization and biogenesis 54 ionic homeostasis organization and biogenesis of cell wall and Protein synthesis 48 plasma membrane Energy 40 ribosomal proteins organization and biogenesis of glycolysis translation (initiation,elongation and cytoskeleton gluconeogenesis termination) organization and biogenesis of endoplasmic pentose-phosphate pathway translational control reticulum and Golgi tricarboxylic-acid pathway tRNA synthetases organization and biogenesis of chromosome respiration other protein-synthesis activities structure fermentation mitochondrial organization and biogenesis metabolism of energy reserves (glycogen Protein destination 49 peroxisomal organization and biogenesis and trehalose) protein folding and stabilization endosomal organization and biogenesis other energy-generation activities protein targeting, sorting and translocation vacuolar and lysosomal
    [Show full text]
  • K319-100 Gluconokinase Activity Assay Kit (Colorimetric)
    FOR RESEARCH USE ONLY! Gluconokinase Activity Assay Kit (Colorimetric) 7/16 (Catalog # K319-100; 100 assays; Store at -20°C) I. Introduction: Gluconokinase (ATP:D-gluconate 6-phosphotransferase or Gluconate Kinase; EC:2.7.1.12) is a key enzyme for Gluconate degradation pathway. In E. coli and yeast, Gluconokinase can convert gluconate into 6-Phosphate-D-Gluconate in an ATP dependent manner. Through Hexose Monophosphate Shunt (HMS) pathway, 6-Phosphate-D-Gluconate generates ribose-6-phosphate, which is critical for nucleotides and nucleic acid synthesis. Little is known of the mechanism of gluconate metabolism in humans despite its widespread use in medicine and consumer products. BioVision’s Gluconokinase Assay kit provides a quick and easy way for monitoring Gluconokinase activity in a variety of samples. In this kit, Gluconokinase converts Gluconate into 6-Phosphate-D-Gluconate in an ATP dependent manner. 6-Phosphate-D-Gluconate and ADP in turn undergoe a series of reactions to form an intermediate, which reacts with the probe to form a colored product with strong absorbance (OD 450 nm). The assay is simple, sensitive, and high-throughput adaptable. Detection limit: < 0.1mU. Gluconokinase D-Gluconate + ATP 6-Phosphate-D-Gluconate + ADP Intermediate + Probe Color Product (OD 450 nm) II. Application: Measurement of Gluconokinase activity in various samples Mechanistic study of Pentose Phosphate Pathway III. Sample Type: Prokaryote such as: E.coli Animal tissues such as liver, kidney, etc. Adherent or suspension cells. IV. Kit Contents: Components K319-100 Cap Code Part Number Gluconokinase Assay Buffer 25 ml WM K319-100-1 Gluconokinase Substrate 1 Vial Blue K319-100-2 ATP 1 Vial Orange K319-100-3 Gluconokinase Converting Enzyme 1 Vial Purple K319-100-4 Gluconokinase Developer 1 Vial Green K319-100-5 Gluconokinase Probe 1 Vial Red K319-100-6 NADH Standard 1 Vial Yellow K319-100-7 Gluconokinase Positive Control 1 Vial Brown K319-100-8 V.
    [Show full text]
  • Human Catechol O-Methyltransferase Genetic Variation
    Molecular Psychiatry (2004) 9, 151–160 & 2004 Nature Publishing Group All rights reserved 1359-4184/04 $25.00 www.nature.com/mp ORIGINAL RESEARCH ARTICLE Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes AJ Shield1, BA Thomae1, BW Eckloff2, ED Wieben2 and RM Weinshilboum1 1Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Medical School, Mayo Clinic, Mayo Foundation, Rochester, MN, USA; 2Department of Biochemistry and Molecular Biology, Mayo Medical School, Mayo Clinic, Mayo Foundation, Rochester, MN, USA Catechol O-methyltransferase (COMT) plays an important role in the metabolism of catecholamines, catecholestrogens and catechol drugs. A common COMT G472A genetic polymorphism (Val108/158Met) that was identified previously is associated with decreased levels of enzyme activity and has been implicated as a possible risk factor for neuropsychiatric disease. We set out to ‘resequence’ the human COMT gene using DNA samples from 60 African-American and 60 Caucasian-American subjects. A total of 23 single nucleotide polymorphisms (SNPs), including a novel nonsynonymous cSNP present only in DNA from African-American subjects, and one insertion/deletion were observed. The wild type (WT) and two variant allozymes, Thr52 and Met108, were transiently expressed in COS-1 and HEK293 cells. There was no significant change in level of COMT activity for the Thr52 variant allozyme, but there was a 40% decrease in the level of activity in cells transfected with the Met108 construct. Apparent Km values of the WT and variant allozymes for the two reaction cosubstrates differed slightly, but significantly, for 3,4-dihydroxybenzoic acid but not for S-adenosyl-L-methionine.
    [Show full text]
  • Branched Chain A-Ketoacid Dehydrogenase to Thiamine and Thiamine Pyrophosphate
    Pediat. Res. 12: 235-238 (1978) Branched chain amino acids thiamine maple syrup urine disease vitamin responsiveness mitochondrial membranes In Vivo and in Vitro Response of Human Branched Chain a-Ketoacid Dehydrogenase to Thiamine and Thiamine Pyrophosphate DEAN J. DANNER,'27' FRANCES B. WHEELER, SANDRA K. LEMMON, AND LOUIS J. ELSAS I1 Department of Pediatrics, Division of Medical Genetics, Emory University School of Medicine, Atlanta, Georgia, USA Summary lability at 37"; and failure to respond to added NAD+, CoASH, and MgZ+. In a homozygous affected patient with maple syrup urine We propose that "excess" thiamine led to increased available disease, pharmacologic doses of thiamine lowered urinary excre- thiamine pyrophosphate which stabilized the branched chain a- tion of branched chain a-ketoacids and stimulated branched ketoacid dehydrogenase, decreased biologic turnover, increased chain a-ketoacid dehydrogenase (BCKAD) in his peripheral enzyme specific activity and produced in vivo tolerance to blood leukocvtes. Suvvlementation of his branched chain ami- branched chain aminoacids in these patients with maple syrup noacid restricted diei hth 100 mglday of thiamine eliminated urine disease. recurrent episodes of ketoacidosis.~heseclinical responses were Speculation studied in vitro using mitochondria1 inner membranes prepared from his cultured skin fibroblasts and those from another By studying the partially purified normal and mutant branched thiamine-responsive patient from Canada. BCKAD in both chain a-ketoacid dehydrogenases from cultured human fibro- mutant cell lines had similarities to normal enzyme including: blasts, direct in vitro effects of thiamine pyrophosphate can be identical apparent K,,, value for thiamine pyrophosphate; similar measured and related to in vivo clinical responses.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Open Matthew R Moreau Ph.D. Dissertation Finalfinal.Pdf
    The Pennsylvania State University The Graduate School Department of Veterinary and Biomedical Sciences Pathobiology Program PATHOGENOMICS AND SOURCE DYNAMICS OF SALMONELLA ENTERICA SEROVAR ENTERITIDIS A Dissertation in Pathobiology by Matthew Raymond Moreau 2015 Matthew R. Moreau Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy May 2015 The Dissertation of Matthew R. Moreau was reviewed and approved* by the following: Subhashinie Kariyawasam Associate Professor, Veterinary and Biomedical Sciences Dissertation Adviser Co-Chair of Committee Bhushan M. Jayarao Professor, Veterinary and Biomedical Sciences Dissertation Adviser Co-Chair of Committee Mary J. Kennett Professor, Veterinary and Biomedical Sciences Vijay Kumar Assistant Professor, Department of Nutritional Sciences Anthony Schmitt Associate Professor, Veterinary and Biomedical Sciences Head of the Pathobiology Graduate Program *Signatures are on file in the Graduate School iii ABSTRACT Salmonella enterica serovar Enteritidis (SE) is one of the most frequent common causes of morbidity and mortality in humans due to consumption of contaminated eggs and egg products. The association between egg contamination and foodborne outbreaks of SE suggests egg derived SE might be more adept to cause human illness than SE from other sources. Therefore, there is a need to understand the molecular mechanisms underlying the ability of egg- derived SE to colonize the chicken intestinal and reproductive tracts and cause disease in the human host. To this end, the present study was carried out in three objectives. The first objective was to sequence two egg-derived SE isolates belonging to the PFGE type JEGX01.0004 to identify the genes that might be involved in SE colonization and/or pathogenesis.
    [Show full text]